Share price
₹162.54 latest close · +31.5% over the last 90 sessions
₹162.54 month-end · +125.0% over 12 months
₹162.54 month-end · +114.0% since Jun '25
52-week range ₹43.98 to ₹181.90 · 1-year volatility 60.0%
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-52.9% (2025-07 peak to 2026-03 low, recovered 2026-06)
-19.5% (2025-06 peak to 2025-06 low, recovered 2025-07)
-17.0% (2026-10 peak to 2026-11 low, not yet recovered)
Most recent volume spikes
2026-10-15: 7.7x the 50-day median, price +3.9% that day
2026-10-12: 16.8x the 50-day median, price +6.8% that day
2026-07-06: 6.6x the 50-day median, price -4.6% that day
Where does it rank among Health Services peers?
Each cell is the company's percentile rank among its Health Services peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE9th▼ 7 pts vs a year ago
- Op. margin6thflat vs a year ago
- Revenue growth18th
- Debt/equity ↓69thflat vs a year ago
- Cash cycle ↓16th▼ 8 pts vs a year ago
- 12M momentum97th
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Health Services sector page Watch it move against Health Services in the Observatory
What is the price implying?
Trailing earnings per share are negative, so a P/E-based figure does not exist. See the loss-makers list on the Expectations Gap page for a revenue-based version.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Health Services The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹162.54
- ROCE
- 5.0%
- Market Cap
- ₹2427 cr
- Revenue (TTM)
- ₹3534 cr
- P/S
- 0.7x
- P/B
- 3.6x
- ROE
- -1.7%
- Operating Margin
- 2.2%
- Debt / Equity
- 0.2x
- Promoter Holding
- 58.0%
- 12M Momentum
- 125.0%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance—Not enough data
Not enough reported data to compute this.
Tax rate—Not enough data
Not enough reported data to compute this.
Cash conversion—Not enough data
Not enough reported data to compute this.
Free cash flow1 of 4 yrsBeyond threshold
Fiscal years with positive free cash flow in the last 4: 1. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history—Not enough data
Not enough reported data to compute this.
Capital work in progress2% of fixed assetsWithin range
Capital work-in-progress is 2% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days—Not enough data
Not enough reported data to compute this.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Since Jun 2025, FIIs trimmed 3.1 pts.
- The number of shareholders fell from 1.2 lakh to 81,683 (-29%) between Jun 2025 and Jun 2026.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like BLUSPRING ENTERPRISES LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −35% to +27% vs the market, against −2% for all non-financial companies in the same months.
- The analogs' median sat below that base rate (gap −14.1%, 80% range −21.4% to −5.9%), but the matches cluster in only 6 distinct 12-month windows.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 4 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 40 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| PGEL Electronic Technology |
Oct 2020 | — | 1% | +155% | −5% | +196% |
| SCI Transportation |
May 2020 | — | 2% | +44% | −31% | +39% |
| HUBTOWN Finance |
Apr 2022 | — | 1% | +299% | −9% | −41% |
| KANORICHEM Process Industries |
Apr 2021 | — | -1% | +298% | −3% | −18% |
| TRANSWORLD Transportation |
May 2021 | — | 3% | +287% | 0% | +92% |
Show the other 3 matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| NAHARINDUS Process Industries |
Apr 2022 | — | 3% | +353% | −8% | −46% |
| TI Consumer Non-Durables |
Nov 2021 | — | 5% | +363% | −12% | +24% |
| JITFINFRA Transportation |
Aug 2021 | — | 4% | +830% | 0% | +100% |
How reliable is this?
Matched on P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: ROCE, interest cover and drawdown from 12-month high. Not used (unavailable for this company): P/E. This company is loss-making, so it was only compared with loss-making companies. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What changed?
8 events since Sep '25
- OctPriceVolume reached 16.8x its 50-day median on 2026-10-12; price +6.8% that day.
- SepResultsRevenue (TTM) reached a new high of ₹3,534 cr.
- JulPriceVolume reached 17.1x its 50-day median on 2026-07-03; price +3.1% that day.
- JunPriceRegained the 2025-07 peak, 3 months after the low.
- JunPriceVolume reached 48.3x its 50-day median on 2026-06-17; price +19.1% that day.
- MarPriceFell 53% from the Jul 2025 peak to the Mar 2026 low.
- MarPriceVolume reached 32.2x its 50-day median on 2026-03-23; price +10.0% that day.
- SepPriceVolume reached 13.3x its 50-day median on 2025-09-16; price +7.1% that day.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history18 months · 2025-06 to 2026-11
| Month | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|
| 2026-11 | ₹3534 cr | -1.7% | 5.0% | 0.2x |
| 2026-10 | ₹3534 cr | -1.7% | 5.0% | 0.2x |
| 2026-09 | ₹3534 cr | -1.7% | 5.0% | 0.2x |
| 2026-08 | ₹3382 cr | -2.2% | 5.0% | 0.2x |
| 2026-07 | ₹3382 cr | -2.2% | 5.0% | 0.2x |
| 2026-06 | ₹3382 cr | -2.2% | 5.0% | 0.2x |
| 2026-05 | ₹3319 cr | -7.2% | 4.0% | 0.2x |
| 2026-04 | ₹3319 cr | -7.2% | 4.0% | 0.2x |
| 2026-03 | ₹3319 cr | -7.2% | 4.0% | 0.2x |
| 2026-02 | ₹3247 cr | -26.6% | 4.0% | 0.2x |
| 2026-01 | ₹3247 cr | -26.6% | 4.0% | 0.2x |
| 2025-12 | ₹3247 cr | -26.6% | 4.0% | 0.2x |
| 2025-11 | ₹3160 cr | -26.9% | 4.0% | 0.2x |
| 2025-10 | ₹3160 cr | -26.9% | 4.0% | 0.2x |
| 2025-09 | ₹3160 cr | -26.9% | 4.0% | 0.2x |
| 2025-08 | ₹3484 cr | -25.8% | 4.0% | 0.2x |
| 2025-07 | ₹3484 cr | -25.8% | 4.0% | 0.2x |
| 2025-06 | ₹3484 cr | -25.8% | 4.0% | 0.2x |